Navigating the Squeeze: Competing with Discount Pharmacies

Australia’s pharmacy sector faces a tough challenge. Traditional pharmacies operate on thin margins, squeezed further by the rise of discount pharmacies. These low-cost competitors attract price-sensitive customers, forcing community pharmacies to rethink their strategies. Surviving this squeeze requires more than just price cuts—it demands smart adaptation, clear differentiation, and a focus on value beyond cost.

This article explores practical ways Australian pharmacies can compete effectively with discount chains while maintaining healthy margins. It highlights real-world examples and actionable steps to help pharmacies thrive despite the pressure.

Understanding the Margin Pressure in Australian Pharmacies

If you run a community pharmacy in Australia right now, you don't need anyone to tell you the maths has changed. Sixty-day dispensing has compressed script revenue. Wages, insurance, rent and compliance costs keep climbing. And on the other side of the shopping centre, a discount giant is selling the same box of medicine at a price you can't match without bleeding. The question that should be occupying every pharmacy owner and CEO in 2026 isn't ‘whether’ the squeeze is real. It's what to do about it  The pharmacies pulling ahead have stopped trying to win a price war they can't win. They're changing the game instead.

You can't out-discount a discounter - so don't try

The big discount chains win on scale: supply chain efficiency, buying power, and a retail model built to move volume at wafer-thin margins. For an independent or mid-size group, matching their shelf price is a race to the bottom with only one winner, and it isn't you.The pharmacies thriving in this environment have accepted a hard truth: if a customer's only question is "who's cheapest?", that customer was never yours to keep. The battle worth fighting is for the customer whose question is "who can actually help me?"

Turn the dispensary into a front door, not the whole house

The single biggest strategic shift in Australian pharmacy is the move from dispensing-led revenue to service-led revenue. Vaccinations, pharmacist prescribing for UTIs and other acute conditions, medication management, chronic disease support, and the expanding full scope of practice programs rolling out across the states all share one feature: a discounter's pricing model can't commoditise a consultation.Every service appointment does three things at once. It generates margin that doesn't depend on PBS remuneration. It brings a patient into your pharmacy for a reason no website can replicate. And it repositions your team in the customer's mind -  from retailer to healthcare provider. That repositioning is the moat.Diversification is also risk management. Owners who leaned on dispensing as a single revenue stream felt the full force of the 60-day policy. Those with services, retail and clinical programs spreading the load absorbed the shock far better. 

Run the business like margins depend on it -  because they do

Differentiation buys you pricing power, but it doesn't excuse loose operations. The strongest operators are doing an annual "financial spring clean": renegotiating leases and insurance, scrutinising rosters against actual foot traffic, and reviewing every recurring expense line.Technology is the force multiplier here. Automated dispensing and stock management systems are saving pharmacies hours of labour every day - hours that get redeployed from the back room to the consultation room, where the margin actually lives. Digital tools for workflow, demand forecasting and customer engagement let a 10-person pharmacy operate with the discipline of a chain, without losing the personality of an independent.

Own the relationship the big box can't have

Here's the asymmetry that works in your favour: a discount warehouse can undercut your price, but it cannot know that Mrs Smith's daughter just moved interstate, that Mr Kowalski gets confused by his Webster pack changes, or that the young mum at the counter is asking about sleep aids because she's really struggling. Community pharmacies that describe themselves as chronic care specialists - and staff, train and market accordingly - are converting trust into loyalty, and loyalty into lifetime value.That means investing in your pharmacists' clinical skills as scope expands, empowering front-of-shop staff to solve problems rather than point at aisles, and being deliberately visible in your community: aged care partnerships, local sporting clubs, school health programs. None of it shows up on a price tag. All of it shows up in retention.

The playbook in brief

The pharmacies that survive the squeeze will be the ones that stop competing on the discounter's terms and start competing on their own:

1. “Exit the price war.”  - Compete on care, access and expertise - not the shelf ticket.

2. “Build service revenue aggressively.”  - Vaccinations, prescribing, medication reviews, chronic care. Treat full scope of practice as your growth engine, not a compliance chore.

3. “Get operationally ruthless.” - Audit costs annually, automate the back room, and measure what matters.

4. “Deepen relationships.” Be the healthcare destination your community trusts by name.

The margin squeeze is real, and it isn't going away. But margin pressure punishes sameness, not smallness. The independents that give patients a reason to walk past the discounter - and keep giving them that reason -  aren't just surviving this market. They're quietly building the pharmacy model the next decade belongs to. 

Case Study: A Community Pharmacy That Thrived

Consider a suburban pharmacy in Melbourne that faced declining sales due to a new discount competitor nearby. Instead of lowering prices, the pharmacy focused on:

• Offering free medication reviews and health checks

• Launching a loyalty program with rewards for regular customers

• Expanding into natural health products and local artisan skincare

• Implementing an easy-to-use online ordering system with home delivery

  
  

Within a year, the pharmacy saw a 15% increase in revenue and improved customer retention. The key was focusing on services and products that discount pharmacies could not match.

Final Thoughts on Surviving the Margin Squeeze

Australian pharmacies face a challenging environment with tight margins and fierce competition from discount chains. Success depends on more than price—it requires building strong customer relationships, diversifying offerings, using technology, and adopting smart pricing.

Pharmacies that focus on their unique strengths as healthcare providers and community hubs can create lasting value. This approach not only helps survive the squeeze but positions them for long-term growth.

For pharmacy owners and managers, the next step is to assess current operations and identify areas to add value beyond price. Small changes in service, product range, or customer engagement can make a big difference in competing effectively.

Cherson advisory is well placed to help navigate these changing dynamics and create a targeted response.